The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: A unique resource for defining the "molecular histology" of the breast

Cancer Prevention Research

Volumn 5, Issue 4, 2012, Pages 528-535

  Sherman, Mark E ^a   Figueroa, Jonine D ^a   Henry, Jill E ^b   Clare, Susan E ^b,c   Rufenbarger, Connie ^b,d   Storniolo, Anna Maria ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Catherine Peachey Fund Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; MESSENGER RNA; PARAFFIN; PROTEIN P53;

ADULT; AGED; BREAST BIOPSY; BREAST CANCER; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RESEARCH; CANCER RISK; COPY NUMBER VARIATION; CPG ISLAND; DNA METHYLATION; FEMALE; GENETIC SUSCEPTIBILITY; HEALTH CARE FACILITY; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; INTRADUCTAL CARCINOMA; LACTATION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NOTE; PREGNANCY; PRIORITY JOURNAL; RACE; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ANIMAL; ARTICLE; BIOPSY; BREAST; BREAST TUMOR; CANCER CENTER; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATHOLOGY; RISK FACTOR; STANDARD; UNITED STATES; UNIVERSITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOPSY; BREAST; BREAST NEOPLASMS; CANCER CARE FACILITIES; FEMALE; HUMANS; INDIANA; MIDDLE AGED; RISK FACTORS; TISSUE BANKS; UNIVERSITIES;

EID: 84864842529     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0234     Document Type: Note

References (34)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010;363:1203-10.
3. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92. (Pubitemid 41549890)
4. Gilliland FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, et al. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 2000;92:743-9. (Pubitemid 30365535)
5. Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE, et al. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 2005;14:1108-12. (Pubitemid 40656455)
6. Cowan WK, Angus B, Gray JC, Lunt LG, al-Tamimi SR. A study of interval breast cancer within the NHS breast screening programme. J Clin Pathol 2000;53:140-6. (Pubitemid 30075059)
7. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996;274:2057-9. (Pubitemid 27020695)
8. Yan PS, Venkataramu C, Ibrahim A, Liu JC, Shen RZ, Diaz NM, et al. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res 2006;12:6626-36. (Pubitemid 44876830)
9. Graham K, Ge X, de Las Morenas A, Tripathi A, Rosenberg CL. Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium. Clin Cancer Res 2011;17:236-46.
10. Troester MA, Lee MH, Carter M, Fan C, Cowan DW, Perez ER, et al. Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res 2009;15:7020-8.
11. Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 1999;188:237-44. (Pubitemid 29317764)
12. Harvey JA, Santen RJ, Petroni GR, Bovbjerg VE, Smolkin ME, Sheriff FS, et al. Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause 2008;15:67-73.
13. Khan SA, Rogers MA, Khurana KK, Meguid MM, Numann PJ. Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 1998;90:37-42. (Pubitemid 28078079)
14. Anderson WF, Matsuno RK, Sherman ME, Lissowska J, Gail MH, Brinton LA, et al. Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control 2007;18:439-47. (Pubitemid 46434789)
15. Russo J, Balogh GA, Heulings R, Mailo DA, Moral R, Russo PA, et al. Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev 2006;15:306-42. (Pubitemid 44060488)
16. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808. (Pubitemid 41430721)
17. Britt K, Ashworth A, Smalley M. Pregnancy and the risk of breast cancer. Endocr Relat Cancer 2007;14:907-33. (Pubitemid 351252427)
18. Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI. Growth patterns and the risk of breast cancer in women. N Engl J Med 2004;351:1619-26. (Pubitemid 39350422)
19. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 1997;99:505-12.
20. Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 2008;100:1643-8.
21. Longacre TA, Bartow SA. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986;10:382-93. (Pubitemid 16066440)
22. Radisky DC, Hartmann LC. Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 2009;14:181-91.
23. Schedin P, O'Brien J, Rudolph M, Stein T, Borges V. Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia 2007;12:71-82. (Pubitemid 46394927)
24. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2011;103:250-63.
25. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 1983;303:767-70. (Pubitemid 13054488)
26. Benz CC. Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol 2008;66:65-74. (Pubitemid 351324129)
27. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, et al. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 2006;98:1600-7. (Pubitemid 44811643)
28. Lee S, Mohsin SK, Mao S, Hilsenbeck SG, Medina D, Allred DC. Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer. Breast Cancer Res 2006;8:R6.
29. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, et al. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 2010;28:2207-12.
30. Degnim AC, Visscher DW, Hoskin TL, Frost MH, Vierkant RA, Vachon CM, et al. Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues. Breast Cancer Res Treat. 2011 Sep 1. [Epub ahead of print].
31. Dotto J, Kluk M, Geramizadeh B, Tavassoli FA. Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: a study of 516 cases. Int J Surg Pathol 2008;16:25-30.
32. Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 1987;60:2751-60. (Pubitemid 17161808)
33. Wong CM, Anderton DL, Smith-Schneider S, Wing MA, Greven MC, Arcaro KF. Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics 2010;5:645-55.
34. Juhl H. Preanalytical aspects: a neglected issue. Scand J Clin Lab Invest Suppl 2010;242:63-5.